{"id":"https://openalex.org/W2159197190","doi":"https://doi.org/10.1152/ajplung.00042.2005","title":"Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice","display_name":"Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice","alternate_titles":[],"publication_year":2005,"publication_date":"2005-09-09","ids":{"openalex":"https://openalex.org/W2159197190","doi":"https://doi.org/10.1152/ajplung.00042.2005","mag":"2159197190","pmid":"https://pubmed.ncbi.nlm.nih.gov/16155090"},"language":"en","primary_location":{"id":"doi:10.1152/ajplung.00042.2005","doi":"https://doi.org/10.1152/ajplung.00042.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1152/ajplung.00042.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47245711","display_name":"American Journal of Physiology-Lung Cellular and Molecular Physiology","issn_l":"1040-0605","issn":["1040-0605","1522-1504"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320155","host_organization_name":"American Physiological Society","host_organization_lineage":["https://openalex.org/P4310320155"],"host_organization_lineage_names":["American Physiological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Physiology-Lung Cellular and Molecular Physiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2159197190"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112639195","display_name":"Shinsuke Murakami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shinsuke Murakami","raw_affiliation_strings":["Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111895804","display_name":"Noritoshi Nagaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Noritoshi Nagaya","raw_affiliation_strings":["National Cerebral and Cardiovascular Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cerebral and Cardiovascular Center","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072128518","display_name":"Takefumi Itoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I64926303","display_name":"Nara Medical University","ror":"https://ror.org/045ysha14","country_code":"JP","type":"education","lineage":["https://openalex.org/I64926303"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takefumi Itoh","raw_affiliation_strings":["Nara Medical Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nara Medical Univ","institution_ids":["https://openalex.org/I64926303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083083314","display_name":"Masaharu Kataoka","orcid":"https://orcid.org/0000-0001-8034-1005","observed_orcids":["https://orcid.org/0000-0001-8034-1005"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masaharu Kataoka","raw_affiliation_strings":["National Cerebral and Cardiovascular Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cerebral and Cardiovascular Center","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100557234","display_name":"Takashi Iwase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takashi Iwase","raw_affiliation_strings":["National Cerebral and Cardiovascular Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cerebral and Cardiovascular Center","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111495636","display_name":"Takeshi Horio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takeshi Horio","raw_affiliation_strings":["National Cerebral and Cardiovascular Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cerebral and Cardiovascular Center","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032492466","display_name":"Yoshinori Miyahara","orcid":"https://orcid.org/0000-0002-1247-9085","observed_orcids":["https://orcid.org/0000-0002-1247-9085"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshinori Miyahara","raw_affiliation_strings":["National Cerebral and Cardiovascular Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cerebral and Cardiovascular Center","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063483183","display_name":"Yoshiki Sakai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshiki Sakai","raw_affiliation_strings":["Ono Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068354355","display_name":"Kenji Kangawa","orcid":"https://orcid.org/0000-0003-4784-5599","observed_orcids":["https://orcid.org/0000-0003-4784-5599"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenji Kangawa","raw_affiliation_strings":["National Cerebral and Cardiovascular Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cerebral and Cardiovascular Center","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036834366","display_name":"Hiroshi Kimura","orcid":"https://orcid.org/0009-0001-1010-2540","observed_orcids":["https://orcid.org/0009-0001-1010-2540"]},"institutions":[{"id":"https://openalex.org/I64926303","display_name":"Nara Medical University","ror":"https://ror.org/045ysha14","country_code":"JP","type":"education","lineage":["https://openalex.org/I64926303"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Kimura","raw_affiliation_strings":["Nara Medical Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nara Medical Univ","institution_ids":["https://openalex.org/I64926303"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5111895804"],"corresponding_institution_ids":["https://openalex.org/I4210111404"],"apc_list":null,"apc_paid":null,"fwci":2.5509,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.891277,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"290","issue":"1","first_page":"L59","last_page":"L65"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ono-1301","display_name":"ONO-1301","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prostacyclin-agonist","display_name":"prostacyclin agonist","score":0.9760000109672546},{"id":"https://openalex.org/keywords/thromboxane-synthase-inhibition","display_name":"thromboxane synthase inhibition","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.8230000138282776},{"id":"https://openalex.org/keywords/bleomycin-induced-lung-injury","display_name":"bleomycin-induced lung injury","score":0.9670000076293945},{"id":"https://openalex.org/keywords/thromboxane-a2","display_name":"thromboxane A2","score":0.9760000109672546},{"id":"https://openalex.org/keywords/camp-pka-signaling","display_name":"cAMP/PKA signaling","score":0.7710000276565552},{"id":"https://openalex.org/keywords/lung-fibroblast-proliferation","display_name":"lung fibroblast proliferation","score":0.8930000066757202},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.6620000004768372},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.8549438714981079},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.671929657459259},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.6192893981933594},{"id":"https://openalex.org/C2777961210","wikidata":"https://www.wikidata.org/wiki/Q927148","display_name":"Bronchoalveolar lavage","level":3,"score":0.5158919095993042},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.5061818957328796},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.503440797328949},{"id":"https://openalex.org/C173202427","wikidata":"https://www.wikidata.org/wiki/Q408575","display_name":"Thromboxane-A synthase","level":4,"score":0.4844363033771515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4690723121166229},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.46621543169021606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4383198022842407},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43789908289909363},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4374871850013733},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.365581214427948},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3226785659790039},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.11220064759254456},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0796779990196228}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D011658","descriptor_name":"Pulmonary Fibrosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011658","descriptor_name":"Pulmonary Fibrosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011658","descriptor_name":"Pulmonary Fibrosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013928","descriptor_name":"Thromboxane A2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017868","descriptor_name":"Cyclic AMP-Dependent Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019010","descriptor_name":"Vascular Cell Adhesion Molecule-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019010","descriptor_name":"Vascular Cell Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1152/ajplung.00042.2005","doi":"https://doi.org/10.1152/ajplung.00042.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1152/ajplung.00042.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47245711","display_name":"American Journal of Physiology-Lung Cellular and Molecular Physiology","issn_l":"1040-0605","issn":["1040-0605","1522-1504"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320155","host_organization_name":"American Physiological Society","host_organization_lineage":["https://openalex.org/P4310320155"],"host_organization_lineage_names":["American Physiological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Physiology-Lung Cellular and Molecular Physiology","raw_type":"journal-article"},{"id":"pmid:16155090","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16155090","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of physiology. Lung cellular and molecular physiology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1488395449","https://openalex.org/W1934130721","https://openalex.org/W1963975820","https://openalex.org/W1964910929","https://openalex.org/W1970981593","https://openalex.org/W1971639723","https://openalex.org/W1995721099","https://openalex.org/W2004872365","https://openalex.org/W2026046897","https://openalex.org/W2029253480","https://openalex.org/W2035665714","https://openalex.org/W2037620883","https://openalex.org/W2042788106","https://openalex.org/W2055931484","https://openalex.org/W2060928333","https://openalex.org/W2061278134","https://openalex.org/W2063586607","https://openalex.org/W2072410689","https://openalex.org/W2075400164","https://openalex.org/W2088675636","https://openalex.org/W2103751591","https://openalex.org/W2110801302","https://openalex.org/W2111301029","https://openalex.org/W2123505629","https://openalex.org/W2128571355","https://openalex.org/W2142988155","https://openalex.org/W2145732660","https://openalex.org/W2149933426","https://openalex.org/W2151461937","https://openalex.org/W2160001887","https://openalex.org/W2163702064","https://openalex.org/W2278927563","https://openalex.org/W2403488629","https://openalex.org/W2412496700","https://openalex.org/W2418525960","https://openalex.org/W3023255269"],"related_works":["https://openalex.org/W2124495536","https://openalex.org/W2976822390","https://openalex.org/W2097834514","https://openalex.org/W2489518248","https://openalex.org/W2154085274","https://openalex.org/W2792301413","https://openalex.org/W2127300944","https://openalex.org/W2770105213","https://openalex.org/W2045236190"],"abstract_inverted_index":{"The":[0,177],"balance":[1],"between":[2],"prostacyclin":[3,38],"and":[4,81,89,122,134,165,224,239],"thromboxane":[5,41],"A2":[6],"(TXA2)":[7],"plays":[8],"an":[9],"important":[10],"role":[11],"in":[12,57,119,138,141,173,179,227,232],"pulmonary":[13,28,55,112,222],"homeostasis.":[14],"However,":[15],"little":[16],"information":[17],"is":[18],"available":[19],"regarding":[20],"the":[21,108,218,242],"therapeutic":[22],"potency":[23],"of":[24,51,62,74,110,147,152,215,220,236,241],"these":[25],"prostanoids":[26],"for":[27,159],"fibrosis.":[29],"We":[30],"have":[31],"recently":[32],"developed":[33],"ONO-1301,":[34],"a":[35,144,166,187,200],"novel":[36],"long-acting":[37],"agonist":[39],"with":[40,143,197],"synthase":[42],"inhibitory":[43],"activity.":[44],"Thus":[45],"we":[46],"investigated":[47],"whether":[48],"repeated":[49,71,213],"administration":[50,73,151,214],"ONO-1301":[52,75,105,126,153,164,183,198,216],"attenuates":[53,217],"bleomycin-induced":[54,111,221],"fibrosis":[56,223],"mice.":[58],"After":[59],"intratracheal":[60],"injection":[61],"bleomycin":[63,93,194,228],"or":[64,76],"saline,":[65],"mice":[66,195],"were":[67,84,102],"randomized":[68],"to":[69],"receive":[70],"subcutaneous":[72],"vehicle.":[77,208],"Bronchoalveolar":[78],"lavage":[79],"(BAL)":[80],"histological":[82],"analyses":[83],"performed":[85],"at":[86,230],"3,":[87],"7,":[88],"14":[90],"days":[91],"after":[92],"injection.":[94],"In":[95,162],"vitro":[96],"studies":[97],"using":[98],"mouse":[99,174],"lung":[100,123,175],"fibroblasts":[101],"also":[103],"performed.":[104],"significantly":[106,127,154,201],"attenuated":[107,185],"development":[109,219],"fibrosis,":[113],"as":[114],"indicated":[115],"by":[116,182,186,234],"significant":[117],"decreases":[118],"Ashcroft":[120],"score":[121],"hydroxyproline":[124],"content.":[125],"reduced":[128,170],"total":[129,135],"cell":[130,171,180],"count,":[131,133],"neutrophil":[132],"protein":[136,188],"level":[137,158],"BAL":[139],"fluid":[140],"association":[142],"marked":[145],"reduction":[146,178],"TXB2.":[148],"A":[149,190],"single":[150],"increased":[155],"plasma":[156],"cAMP":[157,167],">2":[160],"h.":[161],"vitro,":[163],"analog":[168],"dose-dependently":[169],"proliferation":[172,181],"fibroblasts.":[176],"was":[184],"kinase":[189],"(PKA)":[191],"inhibitor.":[192],"Furthermore,":[193],"treated":[196],"had":[199],"higher":[202],"survival":[203,226],"rate":[204],"than":[205],"those":[206],"given":[207],"These":[209],"results":[210],"suggest":[211],"that":[212],"improves":[225],"mice,":[229],"least":[231],"part":[233],"inhibition":[235],"TXA2":[237],"synthesis":[238],"activation":[240],"cAMP/PKA":[243],"pathway.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2159197190","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
